To go where no one has gone before: the necessity of radiobiology studies for exploration beyond the limits of the "Holy Gray" in radionuclide therapy
Eur J Nucl Med Mol Imaging
.
2021 Aug;48(9):2680-2682.
doi: 10.1007/s00259-020-05147-5.
Authors
Frederik A Verburg
1
,
Julie Nonnekens
2
3
4
,
Mark W Konijnenberg
2
5
,
Marion de Jong
2
Affiliations
1
Departments of Radiology and Nuclear Medicine, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, Netherlands. f.verburg@erasmusmc.nl.
2
Departments of Radiology and Nuclear Medicine, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, Netherlands.
3
Departments of Molecular Genetics, Dr. Molewaterplein 40, 3015 GD, Rotterdam, Netherlands.
4
Oncode Institute, Rotterdam, Netherlands.
5
Department of Medical Imaging, Radboud UMC, Nijmegen, Netherlands.
PMID:
33392716
DOI:
10.1007/s00259-020-05147-5
No abstract available
Publication types
Editorial
MeSH terms
Humans
Radiation Protection*
Radiobiology*
Radioisotopes
Substances
Radioisotopes